Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.
Journal: The New England journal of medicine
Published: September 17, 2025
Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.
Journal: The New England journal of medicine
Published: April 16, 2025
Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.
Journal: Drugs in R&D
Published: October 25, 2024
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.
Journal: Drugs in R&D
Published: July 18, 2024
Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII.
Journal: Acta haematologica
Published: September 21, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
Journal: European journal of haematology
Published: March 17, 2023
Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 03, 2023
Medical imaging utilization and associated radiation exposure in children with down syndrome.
Journal: PloS one
Published: November 14, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 04, 2022
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: May 14, 2021
Last Updated: 09/26/2026